Home/Filings/4/0000935836-25-000396
4//SEC Filing

Langsam Jeffrey 4

Accession 0000935836-25-000396

CIK 0001799191other

Filed

May 22, 8:00 PM ET

Accepted

May 23, 1:02 PM ET

Size

4.9 KB

Accession

0000935836-25-000396

Insider Transaction Report

Form 4
Period: 2025-05-21
Langsam Jeffrey
Chief Clinical Officer
Transactions
  • Award

    Common Stock

    2025-05-21+57,38057,380 total
Footnotes (1)
  • [F1]Represents RSU awards that were fully vested upon grant, net of withholding tax obligations.

Documents

1 file

Issuer

Oncology Institute, Inc.

CIK 0001799191

Entity typeother

Related Parties

1
  • filerCIK 0002069752

Filing Metadata

Form type
4
Filed
May 22, 8:00 PM ET
Accepted
May 23, 1:02 PM ET
Size
4.9 KB